Placebo News and Research

RSS

Testosterone fails to influence risk-taking or fairness in men

A large trial reveals that boosting testosterone does not influence men's economic preferences, challenging previous studies linking the hormone to behavior.

29 Sep 2025

Clinical trial disproves claims that antioxidant supplement boosts male fertility

A large Dutch randomized clinical trial (SUMMER) found that a widely marketed antioxidant supplement (Impryl) did not improve ongoing pregnancy rates in men seeking fertility care. Instead, pregnancy success was significantly lower in the critical 4–6 month treatment window, raising safety concerns.

28 Sep 2025

Off-label drug helps one boy with autism speak, parents say. But experts want more data.

Caroline Connor's concerns about her son's development began around his 1st birthday, when she noticed he wasn't talking or using any words. Their pediatrician didn't seem worried, but the speech delay persisted. At 2½, Mason was diagnosed with autism.

26 Sep 2025

Review shows lecanemab and donanemab slow decline and explains who should get them

The Lancet review synthesises evidence on anti beta amyloid monoclonal antibodies and the wider Alzheimer’s care pathway, weighing efficacy, safety, economics, and health system readiness across disease, patient, and population perspectives.

24 Sep 2025

Researchers explore blueberries as a tool to support microbiota in early life

Researchers tested blueberry powder as one of the first complementary foods in human milk-fed infants. The trial found exploratory evidence that blueberries may support healthier gut microbiota development during early life.

24 Sep 2025

BMJ pulls widely cited apple cider vinegar research

BMJ Group has retracted research suggesting that small daily quantities of apple cider vinegar might help people who are overweight or obese to lose weight.

24 Sep 2025

Orforglipron pill improves heart and metabolic risk factors in trial

Patients taking an experimental oral GLP-1 drug lost significant weight and improved their heart and metabolic risk factors in a large, international, phase 3 clinical trial led by investigators at Weill Cornell Medicine, McMaster University, York University and other institutions.

22 Sep 2025

How much apple cider vinegar reduces weight? Meta-analysis points to 30 mL daily

A new meta-analysis of randomized controlled trials shows apple cider vinegar can modestly but significantly reduce body weight, BMI, and waist circumference in adults, particularly those with obesity or type 2 diabetes.

22 Sep 2025

National Institute of Mental Health awards $3.6M grant to advance ADHD medication response research

Approximately 7 million children in the United States between the ages of three and 17 have been diagnosed with attention deficit hyperactivity disorder (ADHD), according to the Centers For Disease Control and Prevention.

19 Sep 2025

Mercury in your hot dog? Vaccine skeptics face their limits at crucial CDC meeting

Public health officials watched with dread as a panel shaped by the Trump administration took up an agenda to begin dismantling six decades of vaccination development and progress.

19 Sep 2025

Oral drug baricitinib shows promise in slowing early type 1 diabetes progression

In 2023, the groundbreaking Australian BANDIT (Baricitinib in New Onset Type 1 Diabetes) trial [1] reported that a daily pill of baricitinib, commonly prescribed for rheumatoid arthritis and alopecia, could safely preserve the body's own insulin production and slow the progression of type 1 diabetes (T1D) in people recently diagnosed with the condition.

19 Sep 2025

New findings support low-dose ATG to delay progression of type 1 diabetes

New research presented at this year's Annual Meeting of the European Association for the Study of Diabetes (EASD) in Vienna, Austria (15-19 September) and published simultaneously in The Lancet shows that a much lower dose than previously thought of the old immunomodulatory drug anti-thymocyte globulin (ATG) is safe and effective in preventing progression of type 1 diabetes (T1D) in young people.

19 Sep 2025

New research aims to use eyedrops to lower lifetime risk of nearsightedness complications

For the first time, researchers are leading a national study to see if the onset of nearsightedness can be delayed – and consequently reduced in magnitude over a lifetime – with the use of eyedrops in young children.

19 Sep 2025

Verapamil shows potential for preserving beta-cell function in type 1 diabetes

New research (the Ver-A-T1D trial) presented at this year's Annual Meeting of the European Association for the Study of Diabetes (EASD) (Vienna, 15-19 September) shows that slow-release (SR) verapamil (360mg daily) could have a potential effect on beta-cell function in adults with newly diagnosed type 1 diabetes.

18 Sep 2025

Oral GLP-1 drug orforglipron achieves significant weight loss in global trial

Patients taking an experimental oral GLP-1 drug lost significant weight and improved their heart and metabolic risk factors in a large, international, phase III clinical trial led by investigators at Weill Cornell Medicine, McMaster University, York University and other institutions

18 Sep 2025

New trial demonstrates efficacy of tirzepatide in children and adolescents with type 2 diabetes

New research shows that that the diabetes/obesity medication tirzepatide can cause clinically meaningful improvements in blood sugar control and weight loss in children and adolescents with type 2 diabetes aged 10-17 years whose diabetes and weight are inadequately controlled with an existing treatment regimen of metformin, insulin, or both.

18 Sep 2025

Daily orforglipron GLP-1 pill achieves over 11% weight loss in global obesity trial

In a phase 3 trial, once-daily oral orforglipron induced significant, dose-dependent weight loss over 72 weeks in adults with obesity but no diabetes. It also improved multiple cardiometabolic markers with a safety profile similar to other GLP-1 receptor agonists.

18 Sep 2025

Clinical trial reveals encouraging results for apitegromab in spinal muscular atrophy

A new clinical trial has revealed encouraging results for a muscle-targeting therapy aimed at improving motor function in children and adolescents with spinal muscular atrophy, according to a study published in The Lancet Neurology.

18 Sep 2025

Investigational drug reduces hot flashes and night sweats for post-menopausal women

The investigational drug elinzanetant significantly reduces hot flashes and night sweats for post-menopausal women, a large, international clinical trial has found.

18 Sep 2025

University of Houston co-leads national study on atropine eyedrops for nearsightedness prevention

The University of Houston is co-leading a national study, the first of its kind in the United States, exploring whether atropine eyedrops can delay the onset of nearsightedness in young children and lessen its progression over a lifetime, a project with potential to shape future standards in vision care.

18 Sep 2025

Placebo News and Research

Testosterone fails to influence risk-taking or fairness in men

Clinical trial disproves claims that antioxidant supplement boosts male fertility

Off-label drug helps one boy with autism speak, parents say. But experts want more data.

Review shows lecanemab and donanemab slow decline and explains who should get them

Researchers explore blueberries as a tool to support microbiota in early life

BMJ pulls widely cited apple cider vinegar research

Orforglipron pill improves heart and metabolic risk factors in trial

How much apple cider vinegar reduces weight? Meta-analysis points to 30 mL daily

National Institute of Mental Health awards $3.6M grant to advance ADHD medication response research

Mercury in your hot dog? Vaccine skeptics face their limits at crucial CDC meeting

Oral drug baricitinib shows promise in slowing early type 1 diabetes progression

New findings support low-dose ATG to delay progression of type 1 diabetes

New research aims to use eyedrops to lower lifetime risk of nearsightedness complications

Verapamil shows potential for preserving beta-cell function in type 1 diabetes

Oral GLP-1 drug orforglipron achieves significant weight loss in global trial

New trial demonstrates efficacy of tirzepatide in children and adolescents with type 2 diabetes

Daily orforglipron GLP-1 pill achieves over 11% weight loss in global obesity trial

Clinical trial reveals encouraging results for apitegromab in spinal muscular atrophy

Investigational drug reduces hot flashes and night sweats for post-menopausal women

University of Houston co-leads national study on atropine eyedrops for nearsightedness prevention

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News